Cancer Immunotherapy Strategic Research Business Report 2023-2030: Improved Delivery Systems, Desire for Non-Toxic Treatments, Checkpoint Inhibitors Spur New Developments and Growth
December 04, 2024 10:55 ET
|
Research and Markets
Dublin, Dec. 04, 2024 (GLOBE NEWSWIRE) -- The "Cancer Immunotherapy - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Cancer...
Cancer Gene Therapy Strategic Business Report 2024: Global Market to Grow by $6.5 Billion by 2030 - Rising Interest in Oncolytic Virus Therapy Generates New Opportunities
November 22, 2024 08:25 ET
|
Research and Markets
Dublin, Nov. 22, 2024 (GLOBE NEWSWIRE) -- The "Cancer Gene Therapy - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Cancer Gene...
Global Oncolytic Virus Immunotherapy Market 2024-2030: IMLYGIC, Oncorine, Delytact Availability, Dosage, Price Analysis,Opportunity & Clinical Trials Insights
September 05, 2024 04:33 ET
|
Research and Markets
Dublin, Sept. 05, 2024 (GLOBE NEWSWIRE) -- The "Global Oncolytic Virus Immunotherapy Market Opportunity & Clinical Trials Insight 2030" report has been added to ResearchAndMarkets.com's...
Oncolytic Virus Therapy Research Report 2024-2030: Market Poised for Expansion Across Multiple Cancer Types, Including Melanoma and Ovarian Cancer
August 22, 2024 04:04 ET
|
Research and Markets
Dublin, Aug. 22, 2024 (GLOBE NEWSWIRE) -- The "Oncolytic Virus Therapy Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's...
Global Oncolytic Immunotherapy Clinical Trials Market Forecast Companies FDA approval Insight
July 11, 2024 07:19 ET
|
KuicK Research
Delhi, July 11, 2024 (GLOBE NEWSWIRE) -- Global Oncolytic Virus Immunotherapy Market Opportunity and Clinical Trials Insight 2030 Report Highlights: Global Oncolytic Virus Immunotherapy Therapy...
Global Oncolytic Virus Therapy Industry Research 2024-2032: Strategic Collaborations to Increase Market Share, Oncolytic Wild-type Viruses Driving Therapeutic Innovation, North America Leads
June 27, 2024 06:03 ET
|
Research and Markets
Dublin, June 27, 2024 (GLOBE NEWSWIRE) -- The "Global Oncolytic Virus Therapy Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies...
Oncology Drugs Market Projected to Surge to $340 Billion by 2031 - Insights Into the Products, Technologies, Grades, Applications, End-users, and Regions
June 25, 2024 12:27 ET
|
Research and Markets
Dublin, June 25, 2024 (GLOBE NEWSWIRE) -- The "Oncology Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application,...
Global Oncolytic Virus Immunotherapy Market & Clinical Trials Insight - A USD 1.50 Billion+ Market Opportunity by 2030
May 14, 2024 08:50 ET
|
Research and Markets
Dublin, May 14, 2024 (GLOBE NEWSWIRE) -- The "Global Oncolytic Virus Immunotherapy Market Opportunity & Clinical Trials Insight 2030" report has been added to ResearchAndMarkets.com's offering....
Global, Oncolytic Virus Therapy Research Report 2024: Market to Reach $53.06 Billion by 2028, Driven by Strategic Partnerships and Rising Awareness
March 04, 2024 11:02 ET
|
Research and Markets
Dublin, March 04, 2024 (GLOBE NEWSWIRE) -- The "Oncolytic Virus Therapy Market - Global Industry Size, Share, Trends, Opportunity, & Forecast 2018-2028" report has been added to ...
Global Oncolytic Virus Therapy Market to Reach Value of USD 2,041.05 Million by 2032 | Emergen Research
November 02, 2023 09:30 ET
|
Emergen Research
Vancouver, Nov. 02, 2023 (GLOBE NEWSWIRE) -- The global oncolytic virus therapy market size is expected to reach USD 2,041.05 Million at a steady CAGR of 23.9% in 2032, according to latest analysis...